Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Hisayasu Nagakura"'
Autor:
Hiroki Shirato, MD, Hideyuki Harada, MD, Yukako Iwasaki, MS, Akifumi Notsu, PhD, Kazunari Yamada, MD, Haruka Uezono, MD, Yutaro Koide, MD, Hitoshi Wada, MD, Hikaru Kubota, MD, Naoto Shikama, MD, Takuya Yamazaki, MD, Kei Ito, MD, Joichi Heianna, MD, Yukinori Okada, MD, Ayako Tonari, MD, Shigeo Takahashi, MD, Takashi Kosugi, MD, Yasuo Ejima, MD, Norio Katoh, MD, Kayo Yoshida, MD, Takafumi Komiyama, MD, Nobue Uchida, MD, Misako Miwa, MD, Miho Watanabe, MD, Hisayasu Nagakura, MD, Tetsuo Saito, MD, Hiroko Ikeda, MD, Isao Asakawa, MD, Tateishi Seiichiro, MD, Takeo Takahashi, MD, Naoyuki Shigematsu, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101205- (2023)
Purpose: The aim of this study was to understand the income and employment status of patients at the start of and during follow-up after palliative radiation therapy for bone metastasis. Methods and Materials: From December 2020 to March 2021, a pros
Externí odkaz:
https://doaj.org/article/1c6f7620d00a474c9c7c602fc474c8a9
Autor:
Tetsuo Saito, MD, PhD, Naoto Shikama, MD, PhD, Takeo Takahashi, MD, PhD, Misako Miwa, MD, PhD, Kazunari Miyazawa, MD, Hitoshi Wada, MD, PhD, Naoki Nakamura, MD, PhD, Atsunori Yorozu, MD, PhD, Hisayasu Nagakura, MD, Mitsunori Miyashita, RN, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100856- (2022)
Purpose: A quality indicator (QI) is a valuable tool to evaluate the quality of health care systems. In palliative radiation oncology, only a few related QIs have been developed to date. In this study, we sought to develop and pilot test QIs that ass
Externí odkaz:
https://doaj.org/article/8d8a8dd6d1594f468940bccd4b9abe9d
Autor:
Hisayasu Nagakura
Publikováno v:
Haigan. 62:951-953
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ec499651f937fd6bba054e78fea134b
https://doi.org/10.2482/haigan.62.951
https://doi.org/10.2482/haigan.62.951
Autor:
Masao Tago, Hisayasu Nagakura, Takashi Kosugi, Hikaru Kubota, Naoto Shikama, Tetsuo Saito, Joichi Heianna, Takeo Takahashi, Terufumi Kawamoto, Miwako Nozaki, Kazunari Yamada, Naoki Nakamura, Kazunari Miyazawa, Masato Fushiki, Ayako Tonari, Hideyuki Harada, Hitoshi Wada, Nobue Uchida, Norio Araki, Shuhei Sekii
Publikováno v:
Japanese Journal of Clinical Oncology. 51:950-955
Background International guidelines recommend brachytherapy for patients with dysphagia from esophageal cancer, whereas brachytherapy is infrequently used to palliate dysphagia in some countries. To clarify the availability of palliative treatment fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b286e6624805c5dfc523bea1973ffa8
https://doi.org/10.1093/jjco/hyab015
https://doi.org/10.1093/jjco/hyab015
Autor:
Nobue Uchida, Hideyuki Harada, Shuhei Sekii, Norio Araki, Tetsuo Saito, Joichi Heianna, Kazunari Yamada, Terufumi Kawamoto, Kei Ito, Naoki Nakamura, Hitoshi Wada, Hikaru Kubota, Hisayasu Nagakura, Masato Fushiki, Ayako Tonari, Naoto Shikama, Takashi Kosugi, Miwako Nozaki, Takeo Takahashi, Masao Tago
Publikováno v:
Journal of Radiation Research
Evidence regarding postoperative radiation therapy (PORT) for metastases to the long bones is lacking. Characterizing the current practice patterns and identifying factors that influence dose-fractionation schedules are essential for future clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0b0b866f9174dbd0585ef66e65c5b4e
https://doi.org/10.1093/jrr/rraa133
https://doi.org/10.1093/jrr/rraa133
Autor:
Hisayasu Nagakura, Hitoshi Wada, Takeo Takahashi, Kazunari Miyazawa, Tetsuo Saito, Naoto Shikama, Naoki Nakamura, Misako Miwa, Mitsunori Miyashita, Atsunori Yorozu
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100856-(2022)
Purpose: A quality indicator (QI) is a valuable tool to evaluate the quality of health care systems. In palliative radiation oncology, only a few of its related QIs have been developed to date. In this study, we sought to develop and pilot test QIs t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2a07d1c74a1c2c9f553e4bd291c890
https://pubmed.ncbi.nlm.nih.gov/35146217
https://pubmed.ncbi.nlm.nih.gov/35146217
Autor:
Hikaru Kubota, Naoki Nakamura, Naoto Shikama, Ayako Tonari, Hitoshi Wada, Hideyuki Harada, Hisayasu Nagakura, Joichi Heianna, Kei Ito, Miwako Nozaki, Masao Tago, Masato Fushiki, Nobue Uchida, Norio Araki, Shuhei Sekii, Takashi Kosugi, Takeo Takahashi, Terufumi Kawamoto, Tetsuo Saito, Kazunari Yamada
BackgroundBecause of the lack of evidence on practice patterns of postoperative radiation therapy (PORT)in patients with metastases to the long bones, it is essential to characterize the current practice patterns and identify factors affecting dose-f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::834470542314764756d23e6f8c2c5e9f
https://doi.org/10.21203/rs.3.rs-45644/v1
https://doi.org/10.21203/rs.3.rs-45644/v1
Autor:
Kazushige Hayakawa, Nobue Uchida, Hirofumi Ogawa, Naoto Shikama, Hitoshi Wada, Kazunari Yamada, Kazunari Miyazawa, Hisayasu Nagakura, Miwako Nozaki, Naoki Nakamura, Hirohisa Katagiri, Hideyuki Harada
Publikováno v:
Japanese journal of clinical oncology. 51(1)
Purpose Palliative radiotherapy is the standard of care for bone metastases. However, skeletal-related events, defined as a pathologic fracture, paraplegia, surgery or radiotherapy for local recurrence, or severe pain in previously irradiated bone wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce8b1b8de8653ae14ad646d2f461d14
https://pubmed.ncbi.nlm.nih.gov/32869095
https://pubmed.ncbi.nlm.nih.gov/32869095
Autor:
Mitsuhiro Takemoto, Hirobumi Oikawa, Masao Kobayashi, Tetsuro Tamamoto, Fumiaki Isohashi, Hisayasu Nagakura, Naoto Kanesaka, Kazuo Hatano, Hiroshi Onishi, Kazuhiko Ogawa, Kenji Nemoto, Katsuyuki Karasawa, Takashi Kosugi, Hideya Yamazaki, Yasumasa Nishimura, Yoshinori Ito, Yasuhiro Kosaka, Makoto Takayama, Yasuo Yoshioka, Michiko Imai
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 89:822-829
Purpose To determine whether adding intraluminal brachytherapy (ILBT) to definitive radiation therapy (RT) for unresectable biliary tract cancer has a positive impact on survival outcome. Methods and Materials The original cohort comprised 209 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d4f50f90dc8dd12c18e56602e395c4
https://doi.org/10.1016/j.ijrobp.2014.04.020
https://doi.org/10.1016/j.ijrobp.2014.04.020
Autor:
Shuhei Sekii, Kazunari Yamada, Hideyuki Harada, Hisayasu Nagakura, Naoki Nakamura, Joichi Heianna, Norio Araki, Masato Fushiki, Ayako Tonari, Masao Tago, Hikaru Kubota, Naoto Shikama, Tetsuo Saito, T. Kawamoto, Takashi Takahashi, Takashi Kosugi, Miwako Nozaki, Hitoshi Wada, Nobue Uchida
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:E577
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67e38d0a5d792fe17162cdf87e7bad54
https://doi.org/10.1016/j.ijrobp.2019.06.1250
https://doi.org/10.1016/j.ijrobp.2019.06.1250